REGINA CHIMILESKI: Open Payments
NPI 1598479586 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,647 in 127 payments from 19 companies in 2025. Trend: 2023 $1,850 · 2024 $3,639 · 2025 $2,647
Food & beverage: $2,637Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $713 |
| Incyte Corporation | 15 | $395 |
| Janssen Biotech, Inc. | 13 | $314 |
| LEO Pharma Inc. | 10 | $254 |
| PFIZER INC. | 12 | $200 |
| UCB, Inc. | 5 | $176 |
| Galderma Laboratories, L.P. | 5 | $101 |
| Amgen Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $61 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $61 |
Products named: OPZELURA, SKYRIZI, RINVOQ, TREMFYA, ADBRY, CIBINQO, Bimzelx, OTEZLA.
Industry payments across CT — which companies pay providers there.
